Packaging materials manufacturer Tekni-Plex has completed the acquisition of Belgium-based extruder and converter of polyethylene (PE) film Beyers Plastics from investment company Famo.

Established in 1970, Beyers Plastics provides flexible packaging solutions to pharmaceutical companies and other blue-chip companies in various industries.

Under the terms of the deal, Beyers will now join Tekni-Plex’s Tekni-Films business unit, which produces PE packaging for various industries such as pharmaceutical, medical, food and chemicals.

Tekni-Films global senior vice-president and general manager Joe Horn said: “The acquisition of Beyers Plastics allows us to expand our portfolio of cleanroom-produced pharmaceutical and medical flexible packaging products.

“For the first time, we will have bag-converting capability, as well as PE-blown film extrusion. The acquisition supports our goal of expanding our offerings in the pharmaceutical and healthcare space.”

“The acquisition of Beyers Plastics allows us to expand our portfolio of cleanroom-produced pharmaceutical and medical flexible packaging products.”

In the past four years, Tekni-Plex has completed the acquisition of ten companies that offer plastic and rubber products, including Beyers Plastics, to further drive its growth.

Beyers Plastics general manager Johan Noelmans said: “We look forward to becoming part of Tekni-Plex’s global healthcare packaging presence.

“Our combined expertise and manufacturing capability will provide packaging solutions for more companies, as well as grow sales for our combined product lines.”

Headquartered in Wayne, Pennsylvania, US, Tekni-Plex develops and manufactures packaging materials, medical compounds and medical tubing solutions for various industries. It currently operates manufacturing sites across eight countries globally.

Free Whitepaper How electronic inspection sensors prevented a potentially extremely costly product recall

A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. This document explains how DJA Pharma prevented a costly recall with a simple, elegant and effective solution.

Enter your details here to receive your free whitepaper.

Machinery whitepaper

Download our whitepaper

Yes I have read and accept the terms and conditions and privacy policys.


You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our Verdict Privacy Policy to see how we protect and manage your submitted data.

You will receive your free whitepaper after you submit the form.

Close